Corrigendum: Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study

• Christina Ricci,
• Divya Subburaj,
• Kate Lim,
• Neetu Shukla,
• Jaskiran Kaur,
• Lin Xie,
• Meghan Laverty,
• Dianne Zakaria,
• Jason Pole,
• Jason Pole,
• Marie-Claude Pelland-Marcotte,
• Marie-Claude Pelland-Marcotte,
• Randy Barber,
• Sara J. Israels,
• Thai-Hoa Tran,
• Thai-Hoa Tran,
• Sapna Oberoi,
• Sapna Oberoi,
• Samuele Renzi,
• Samuele Renzi,
• Tamara MacDonald,
• Tamara MacDonald,
• Lillian Sung,
• Lillian Sung,
• Ketan Kulkarni

Affiliations

Christina Ricci

Lifespan Chronic Disease and Conditions Division, Public Health Agency of Canada, Ottawa, ON, Canada

Divya Subburaj

Department of Pediatrics, Division of Hematology-Oncology, Izzak Walton Killam (IWK) Health Centre, Halifax, NS, Canada

Kate Lim

Faculty of Medicine, Dalhousie University, Halifax, NS, Canada

Neetu Shukla

Lifespan Chronic Disease and Conditions Division, Public Health Agency of Canada, Ottawa, ON, Canada

Jaskiran Kaur

Surveillance Systems and Data Management Division, Public Health Agency of Canada, Ottawa, ON, Canada

Lin Xie

Lifespan Chronic Disease and Conditions Division, Public Health Agency of Canada, Ottawa, ON, Canada

Meghan Laverty

Lifespan Chronic Disease and Conditions Division, Public Health Agency of Canada, Ottawa, ON, Canada

Dianne Zakaria

Lifespan Chronic Disease and Conditions Division, Public Health Agency of Canada, Ottawa, ON, Canada

Jason Pole

Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

Jason Pole

Centre for Health Sciences Research, University of Queensland, Brisbane, QLD, Australia

Marie-Claude Pelland-Marcotte

Division of Pediatric Hematology-Oncology, CHU de Québec-Centre Mère-Enfant Soleil, Quebec City, QC, Canada

Marie-Claude Pelland-Marcotte

Research Centre of the CHU de Québec, Axe Reproduction, Santé de la Mère et de l’Enfant, Quebec City, QC, Canada

Randy Barber

C17 Research Network, C17 Council, Edmonton, AB, Canada

Sara J. Israels

0Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada

Thai-Hoa Tran

1Department of Pediatrics, Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada

Thai-Hoa Tran

2Immune Diseases and Cancers Axis, CHU Sainte-Justine Research Center, Montréal, QC, Canada

Sapna Oberoi

0Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada

Sapna Oberoi

3Department of Pediatric Hematology-Oncology, CancerCare Manitoba, Winnipeg, MB, Canada

Samuele Renzi

4Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON, Canada

Samuele Renzi

5Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy

Tamara MacDonald

6Department of Pharmacy, Izzak Walton Killam (IWK) Health, Halifax, NS, Canada

Tamara MacDonald

7Faculty of Health Professions, Dalhousie University, Halifax, NS, Canada

Lillian Sung

4Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON, Canada

Lillian Sung

8Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada

Ketan Kulkarni

Department of Pediatrics, Division of Hematology-Oncology, Izzak Walton Killam (IWK) Health Centre, Halifax, NS, Canada